felodipine

Generic: felodipine

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name felodipine
Generic Name felodipine
Labeler chartwell rx, llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

felodipine 5 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-647
Product ID 62135-647_459bc915-c26d-844b-e063-6394a90a5c13
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210847
Listing Expiration 2026-12-31
Marketing Start 2019-08-01

Pharmacologic Class

Established (EPC)
dihydropyridine calcium channel blocker [epc]
Mechanism of Action
calcium channel antagonists [moa]
Chemical Structure
dihydropyridines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135647
Hyphenated Format 62135-647

Supplemental Identifiers

RxCUI
402695 402696 402698
UPC
0362135648909 0362135646905 0362135647902
UNII
OL961R6O2C
NUI
N0000000069 N0000175421 M0006414

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name felodipine (source: ndc)
Generic Name felodipine (source: ndc)
Application Number ANDA210847 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-647-90)
source: ndc

Packages (1)

Ingredients (1)

felodipine (5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "459bc915-c26d-844b-e063-6394a90a5c13", "openfda": {"nui": ["N0000000069", "N0000175421", "M0006414"], "upc": ["0362135648909", "0362135646905", "0362135647902"], "unii": ["OL961R6O2C"], "rxcui": ["402695", "402696", "402698"], "spl_set_id": ["fddebfce-70ed-4ee1-8598-bbb8f1ca9263"], "pharm_class_cs": ["Dihydropyridines [CS]"], "pharm_class_epc": ["Dihydropyridine Calcium Channel Blocker [EPC]"], "pharm_class_moa": ["Calcium Channel Antagonists [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62135-647-90)", "package_ndc": "62135-647-90", "marketing_start_date": "20230605"}], "brand_name": "Felodipine", "product_id": "62135-647_459bc915-c26d-844b-e063-6394a90a5c13", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "62135-647", "generic_name": "Felodipine", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Felodipine", "active_ingredients": [{"name": "FELODIPINE", "strength": "5 mg/1"}], "application_number": "ANDA210847", "marketing_category": "ANDA", "marketing_start_date": "20190801", "listing_expiration_date": "20261231"}